Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each fractionally lower.
The iShares Biotechnology ETF (IBB) shed 0.9%.
In corporate news, Gilead Sciences (GILD) has agreed to acquire Germany-based Tubulis for up to $5 billion, aiming to expand its oncology pipeline. Gilead shares were down 1.2%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments